Tranzyme, Ocera Announce Merger Agreement
April 23, 2013 at 20:41 PM EDT
Tranzyme Pharma (NASDAQ: TZYM ) and Ocera Therapeutics, Inc. ("Ocera"), a privately held biopharmaceutical company developing novel therapeutics for liver diseases, today announced that they have entered into a definitive agreement under which Ocera will merge with a subsidiary of Tranzyme in an all-stock transaction. The merger is expected
